SYNTAX II: CABG-LIKE OUTCOMES WITH SYNERGY™ BP STENT AND STATE-OF-THE-ART PCI STRATEGY

The SYNTAX II Trial evaluated the SYNERGY™ BP-EES Stent in a procedure-related trial involving a multitude of variables when treating patients with three-vessel disease including:

The SYNTAX II Trial evaluated the SYNERGYTM BP-EES Stent The SYNTAX II Trial evaluated the SYNERGYTM BP-EES Stent


The 12 month results were then compared to the PCI and CABG arms of the original SYNTAX I Trial as historical comparators. So what did we learn?